ClassID:

21090

A61K39/04 - page 3 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies; Bacterial antigens Mycobacterium, e.g. Mycobacterium tuberculosis

Recent Application in this class:
#601
20100166840
2010-07-01

LIPOSOME HAVING LIPID MEMBRANE CONTAINING BACTERIAL CELL COMPONENT

#602
20100166786
2010-07-01

fusion protein and uses thereof

#603
20100150966
2010-06-17

METHOD FOR THE DIAGNOSIS OF TUBERCULOSIS

#604
20100150893
2010-06-17

Methods and compositions for treating autoimmune diseases

#605
20100129407
2010-05-27

Tuberculosis vaccine

#606
20100129391
2010-05-27

Immunogenic compositions comprising polypeptides and fusions thereof

#607
20100119535
2010-05-13

Compositions and methods for immunodominant antigens

#608
20100112008
2010-05-06

TUBERCULOSIS NUCLEIC ACIDS, POLYPEPTIDES AND IMMUNOGENIC COMPOSITIONS

#609
20100112007
2010-05-06

Tuberculosis vaccine and method of using same

#610
20100112004
2010-05-06

Hypoxia inducible factor inducer and methods for using the same

#611
20100092518
2010-04-15

Recombinant intracellular pathogen immunogenic compositions and methods of use

#612
20100068258
2010-03-18

Prophylactic tuberculosis vaccine

#613
20100047286
2010-02-25

Recombinant BCG strains with enhanced ability to escape the endosome

#614
20100047272
2010-02-25

Therapeutic vaccine comprising mycobacterial heat shock protein 70

#615
20100034855
2010-02-11

Compositions for eliciting an immune response against subspecies

#616
20100016415
2010-01-21

Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines

#617
20100015171
2010-01-21

VACCINES COMPRISING TB 10.4

#618
20100015096
2010-01-21

Fusion proteins of mycobacterium tuberculosis

#619
20100008951
2010-01-14

Flu vaccine admixture of mannan and flu antigen

#620
20100003219
2010-01-07

Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response

#621
20090324702
2009-12-31

Recombinant baculovirus vaccine

#622
20090324503
2009-12-31

Methods for detecting a infection

#623
20090306195
2009-12-10

Fusion proteins of

#624
20090304750
2009-12-10

NOVEL PRIME-BOOST COMBINATIONS OF ATTENUATED MYCOBACTERIUM

#625
20090304749
2009-12-10

Method of producing rough strains of bacteria and uses thereof

#626
20090304637
2009-12-10

RECOMBINANT MYCOBACTERIUM STRAIN EXPRESSING A MYCOBACTERIAL FAP PROTEIN UNDER THE CONTROL OF A PROMOTER ACTIVE UNDER HYPOXIA AND ITS APPLICATION FOR CANCER THERAPY

#627
20090286734
2009-11-19

Pharmaceutical Use of Alpha Antigen or Alpha Antigen Gene

#628
20090285847
2009-11-19

Compositions and methods for immunodominant antigens of

#629
20090274651
2009-11-05

Therapeutic agent for infections, and treatment method using the same

#630
20090263418
2009-10-22

MEANS AND METHODS FOR MANIPULATING SEQUENTIAL PHAGOLYSOMALCYTOSOLIC TRANSLOCATION OF MYCOBACTERIA, AND USES THEREOF

#631
20090226489
2009-09-10

Viral vaccine composition, process and methods of use

#632
20090203593
2009-08-13

Immunogenic constructs

#633
20090196887
2009-08-06

Immunogenic compositions for activating γδ T cells

#634
20090186048
2009-07-23

Tuberculosis vaccines comprising antigens expressed during the latent infection phase

#635
20090181078
2009-07-16

VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

#636
20090175901
2009-07-09

Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use

#637
20090175798
2009-07-09

Mycobacterial Catalase-Peroxidase in the Diagnosis and Treatment of Sarcoidosis

#638
20090148473
2009-06-11

Microbial vaccine and vaccine vector

#639
20090136534
2009-05-28

Recombinant BCG tuberculosis vaccine designed to elicit immune responses to in all physiological stages of infection and disease

#640
20090130074
2009-05-21

Preparation of antigen-presenting human γδ T cells and use in immunotherapy

#641
20090124549
2009-05-14

Methods for producing an immune response to tuberculosis

#642
20090123492
2009-05-14

Generation of new BCG vaccine strains protecting against the establishment of latent infection and reactivation from the latent or persistent state

#643
20090123491
2009-05-14

Method for preventing or treating infection

#644
20090123438
2009-05-14

Multivalent vaccines comprising recombinant viral vectors

#645
20090092666
2009-04-09

Vaccines with enhanced immune response and methods for their preparation

#646
20090092636
2009-04-09

Multivalent PCV2 immunogenic compositions and methods of producing such compositions

#647
20090081155
2009-03-26

Pharmaceutical compositions containing 1-methyl-D-tryptophan

#648
20090074853
2009-03-19

Vaccines with enhanced immune response and methods for their preparation

#649
20090074815
2009-03-19

Immunomodulator Compounds as Vaccine Enhancers

#650
20090068222
2009-03-12

Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response

#651
20090060954
2009-03-05

Recombinant BCG vaccine

#652
20090022742
2009-01-22

Compounds and methods for diagnosis and immunotherapy of tuberculosis

#653
20090018095
2009-01-15

Fusion proteins of mycobacterium tuberculosis

#654
20090004226
2009-01-01

Fusion proteins of mycobacterium tuberculosis

#655
20080317785
2008-12-25

Vaccine

#656
20080317716
2008-12-25

Fusion proteins of mycobacterium tuberculosis

#657
20080311159
2008-12-18

Methods and Means for Diagnostics, Prevention and Treatment of Mycobacterium Infections and Tuberculosis Disease

#658
20080293103
2008-11-27

Stress protein compositions and methods for prevention and treatment of cancer and infectious disease

#659
20080286852
2008-11-20

Electroporation of and overexpression of antigens in mycobacteria

#660
20080279812
2008-11-13

Disease Prevention and Vaccination Prior to Thymic Reactivation

#661
20080269151
2008-10-30

Fusion proteins of

#662
20080260782
2008-10-23

subspecies vaccines and methods of using the same

#663
20080260763
2008-10-23

High Throughput Proteomics

#664
20080241182
2008-10-02

MYCOBACTERIUM TUBERCULOSIS PERSISTANCE GENES

#665
20080233153
2008-09-25

Vaccine compositions and adjuvant

#666
20080226678
2008-09-18

Compositions for immunizing against mycobacterium

#667
20080226669
2008-09-18

MULTIVALENT PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS

#668
20080199493
2008-08-21

Siv and Hiv Vaccination Using Rhcmv- and Hcmv-Based Vaccine Vectors

#669
20080193463
2008-08-14

Mycoplasma subunit vaccine

#670
20080176798
2008-07-24

Compounds and methods for diagnosis and immunotherapy of tuberculosis

#671
20080161263
2008-07-03

Fusion proteins of Mycobacterium tuberculosis

#672
20080147131
2008-06-19

Method for muscle delivery of drugs, nucleic acids and other compounds

#673
20080138356
2008-06-12

Pili from

#674
20080132463
2008-06-05

Pharmaceutical use of α antigen or α antigen gene

#675
20080131466
2008-06-05

Vaccine composition containing synthetic adjuvant

#676
20080107683
2008-05-08

Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses Thereof

#677
20080103095
2008-05-01

Stress protein compositions and methods for prevention and treatment of cancer and infectious disease

#678
20080095794
2008-04-24

Recombinant BCG strains with enhanced ability to escape the endosome

#679
20080008724
2008-01-10

Expanding the T cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails

#680
20070292454
2007-12-20

Therapeutic calcium phosphate particles and methods of manufacture and use

#681
20070292452
2007-12-20

Vaccine Compositions Which Are Obtained From Streptomyces

#682
20070292449
2007-12-20

Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses

#683
20070269501
2007-11-22

Immunotherapeutic agent for the combined treatment of tuberculosis in association with other drugs

#684
20070259007
2007-11-08

Lactoferrin: an adjuvant for vaccines

#685
20070231301
2007-10-04

PARENTERAL LOW DOSE TYPE 1 INTERFERONS FOR BLADDER CANCER

#686
20070224123
2007-09-27

Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines

#687
20070224122
2007-09-27

Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines

#688
20070218086
2007-09-20

Adjuvant Composition and Methods for Its Use

#689
20070202131
2007-08-30

Use of mycrobacterial vaccines in CD4 or CD8 lymphocyte-deficient mammals

#690
20070148689
2007-06-28

Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases

#691
20070148254
2007-06-28

COMPOSITIONS AND METHODS FOR DELIVERY OF PROTEINS AND ADJUVANTS ENCAPSULATED IN MICROSPHERES

#692
20070134274
2007-06-14

Vaccine candidates against Johne's disease

#693
20070134273
2007-06-14

Composition and method for the treatment of carcinoma

#694
20070128216
2007-06-07

Recombinant intracellular pathogen immunogenic compositions and methods for use

#695
20070122420
2007-05-31

Protein antigens useful for cancer therapy and vaccination

#696
20070116719
2007-05-24

Vaccine delivery

#697
20070116714
2007-05-24

Vaccine Comprising a Polysaccharide Antigen-Carrier Protein Conjugate and Free Carrier Protein

#698
20070059328
2007-03-15

Process for manufacturing pharmaceutical composition comprises of in the treatment of asthma (obstructive lung disease)

#699
20070054336
2007-03-08

Compounds and methods for diagnosis and immunotherapy of tuberculosis

#700
20070026473
2007-02-01

Antibody profiles characteristic of tuberculosis state

#701
20070026057
2007-02-01

In vivo targeting of dendritic cells

#702
20070026020
2007-02-01

Modified mycobacterium tuberculosis strains and uses thereof

#703
20070009547
2007-01-11

Modified ESAT-6 molecules and improved vaccine strains of BCG

#704
20070009545
2007-01-11

Mycoplasma subunit vaccine

#705
20060292169
2006-12-28

Fusion proteins of antigens and their uses

#706
20060292168
2006-12-28

Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same

#707
20060286128
2006-12-21

Adjuvant combinations of liposomes and mycobacteriaial lipids for immunization compositions and vaccines

#708
20060257423
2006-11-16

HBsAg-BCG combined vaccine for intracutaneous injection and preparation method thereof

#709
20060210586
2006-09-21

Recombinant BCG vaccine

#710
20060193876
2006-08-31

Fusion proteins of

#711
20060193875
2006-08-31

Method of treating human-immunodeficiency virus (HIV) disease infection

#712
20060182754
2006-08-17

Abundant extracellular products and methods for their production and use

#713
20060177461
2006-08-10

Stress proteins and uses therefor

#714
20060177460
2006-08-10

Stress proteins and uses therefor

#715
20060153880
2006-07-13

Pharmaceutical use of alpha antigen or alpha antigen gene

#716
20060147473
2006-07-06

Mycobacterium cell wall composition

#717
20060140982
2006-06-29

Tuberculosis nucleic acids, polypeptides and immunogenic compositions

#718
20060140975
2006-06-29

Regulated bacterial lysis for gene vaccine vector delivery and antigen release

#719
20060135906
2006-06-22

Iontophoretic device and method for administering immune response-enhancing agents and compositions

#720
20060134136
2006-06-22

Whole bacterial cells as immune modulator

#721
20060121054
2006-06-08

Transformed bacterium lacking selectable marker and overexpression of antigens in mycobacteria

#722
20060115494
2006-06-01

Recombinant BCG strains with attenuated immunosuppressive properties

#723
20060041219
2006-02-23

Method for muscle delivery of drugs, nucleic acids and other compounds

#724
20060034764
2006-02-16

Fusion proteins of mycobacterium tuberculosis antigens and their uses

#725
20060029620
2006-02-09

Mycobacterium smegmatis vaccine

#726
20060013821
2006-01-19

Vaccine compositions and adjuvant

#727
20060008519
2006-01-12

Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids

#728
20060002941
2006-01-05

Compositions comprising immune response altering agents and methods of use

#729
20050232946
2005-10-20

Vaccine against microbial pathogens

#730
20050220811
2005-10-06

Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of BCG and

#731
20050202035
2005-09-15

Stress protein compositions and methods for prevention and treatment of cancer and infectious disease

#732
20050191308
2005-09-01

Adjuvant combinations for immunization composition and vaccines

#733
20050180963
2005-08-18

Probiotic propionibacterium

#734
20050175635
2005-08-11

Method and composition

#735
20050163792
2005-07-28

Stress proteins and uses therefor

#736
20050129707
2005-06-16

Vaccine comprising a polysaccharide antigen - carrier protein conjugate and free carrier protein

#737
20050118201
2005-06-02

Mycobacterial vaccine

#738
20050058663
2005-03-17

Mycobacterium avium subspecies paratuberculosis oral vaccine and methods

#739
20050025783
2005-02-03

Vaccine

#740
20050025747
2005-02-03

Vaccine

#741
20050019339
2005-01-27

Vaccines with enhanced immune response and methods for their preparation

#742
18307998
2024-08-27

Double auxotrophic mycobacterium and uses thereof

#743
16932331
2022-06-21

Bacillus Calmette-Guerin (BCG) and antigen presenting cells for treatment of bladder cancer